TRU-015, a small modular immunopharmaceutical (SMIP™) drug candidate directed against CD20, demonstrates clinical improvement in subjects with rheumatoid arthritis

por Burge, DJ, Shu, C, Martin, RW, Littlejohn, TW, Wallace, DJ, Taborn, J, Palmer, WR, Kivitz, A
Publicado 2007